Gene Expression Signature Technology to Repurpose Drugs for Bipolar Disorder [ 2015 - 2017 ]

Research Grant

Researchers: Prof Ken Walder (Principal investigator) ,  Prof Brian Dean ,  Prof Marion Leboyer ,  Prof Michael Berk

Brief description In this project we will generate a Gene Expression Signature that best characterises the overall biological effects of a cocktail of drugs currently used to treat bipolar disorder. The Signature will be identified in cells and intact brains, and then validated using human gene expression profiling. The validated Signature will then be used to screen libraries and discover new drugs for treating bipolar disorder.

Funding Amount $AUD 482,800.07

Funding Scheme Project Grants

Notes Standard Project Grant